IGF1 and breast cancer: We observed the effect of IGF-I on proliferation of the OVCAR3 cell line in serum-free conditions and protection of the cells from cytotoxic effects of carboplatin or taxol similarly to that observed with doxorubicin in MCF7 human breast cancer (30) and carboplatin in ovarian cancer (31).